Prevalence of Metabolic Syndrome and Related Characteristics in Obese Adolescents with and without Polycystic Ovary Syndrome
Context: Adults with polycystic ovary syndrome (PCOS) may be at increased risk for metabolic syndrome (MBS) and related cardiovascular disease. It is not clear whether PCOS diagnosed in adolescence increases the risk of MBS in this age group. Objective: The aim was to compare the prevalence and rela...
Saved in:
Published in | The journal of clinical endocrinology and metabolism Vol. 93; no. 12; pp. 4780 - 4786 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Bethesda, MD
Oxford University Press
01.12.2008
Endocrine Society The Endocrine Society |
Subjects | |
Online Access | Get full text |
ISSN | 0021-972X 1945-7197 |
DOI | 10.1210/jc.2008-1198 |
Cover
Abstract | Context: Adults with polycystic ovary syndrome (PCOS) may be at increased risk for metabolic syndrome (MBS) and related cardiovascular disease. It is not clear whether PCOS diagnosed in adolescence increases the risk of MBS in this age group.
Objective: The aim was to compare the prevalence and related characteristics of MBS in obese adolescents with and without PCOS.
Design: We conducted a cross-sectional study of overweight and obese PCOS adolescents and BMI matched controls.
Patients and Participants: A total of 74 subjects, 43 with PCOS and 31 controls, participated in the study.
Interventions: Each subject underwent a physical examination and laboratory evaluation for a diagnosis of MBS. Regional fat distribution was determined by computerized tomography scan in the PCOS adolescents.
Main Outcome Measures: We measured the prevalence of MBS and its components in adolescent subjects and controls.
Results: The PCOS group had larger ovarian volume and higher measures of total testosterone and free androgen index than controls, but there were no differences in waist circumference, fasting glucose, blood pressure, or lipids. PCOS adolescents demonstrated more glucose abnormalities and higher plasminogen activator inhibitor-1. By pediatric criteria, 53% of the PCOS and 55% of the control adolescents had MBS. By adult criteria, 26% of PCOS and 29% of controls met diagnostic criteria for MBS.
Conclusions: Obese adolescent women have a high prevalence of MBS, and PCOS does not add additional risk for MBS. There appears to be an association between MBS and visceral adiposity. PCOS is associated with increased incidence of glucose intolerance and increased plasminogen activator inhibitor-1. Our results reinforce the importance of obesity counseling in adolescents to recognize the possible risk of future cardiovascular disease in these young women. |
---|---|
AbstractList | Context: Adults with polycystic ovary syndrome (PCOS) may be at increased risk for metabolic syndrome (MBS) and related cardiovascular disease. It is not clear whether PCOS diagnosed in adolescence increases the risk of MBS in this age group.
Objective: The aim was to compare the prevalence and related characteristics of MBS in obese adolescents with and without PCOS.
Design: We conducted a cross-sectional study of overweight and obese PCOS adolescents and BMI matched controls.
Patients and Participants: A total of 74 subjects, 43 with PCOS and 31 controls, participated in the study.
Interventions: Each subject underwent a physical examination and laboratory evaluation for a diagnosis of MBS. Regional fat distribution was determined by computerized tomography scan in the PCOS adolescents.
Main Outcome Measures: We measured the prevalence of MBS and its components in adolescent subjects and controls.
Results: The PCOS group had larger ovarian volume and higher measures of total testosterone and free androgen index than controls, but there were no differences in waist circumference, fasting glucose, blood pressure, or lipids. PCOS adolescents demonstrated more glucose abnormalities and higher plasminogen activator inhibitor-1. By pediatric criteria, 53% of the PCOS and 55% of the control adolescents had MBS. By adult criteria, 26% of PCOS and 29% of controls met diagnostic criteria for MBS.
Conclusions: Obese adolescent women have a high prevalence of MBS, and PCOS does not add additional risk for MBS. There appears to be an association between MBS and visceral adiposity. PCOS is associated with increased incidence of glucose intolerance and increased plasminogen activator inhibitor-1. Our results reinforce the importance of obesity counseling in adolescents to recognize the possible risk of future cardiovascular disease in these young women. Context: Adults with polycystic ovary syndrome (PCOS) may be at increased risk for metabolic syndrome (MBS) and related cardiovascular disease. It is not clear whether PCOS diagnosed in adolescence increases the risk of MBS in this age group. Objective: The aim was to compare the prevalence and related characteristics of MBS in obese adolescents with and without PCOS. Design: We conducted a cross-sectional study of overweight and obese PCOS adolescents and BMI matched controls. Patients and Participants: A total of 74 subjects, 43 with PCOS and 31 controls, participated in the study. Interventions: Each subject underwent a physical examination and laboratory evaluation for a diagnosis of MBS. Regional fat distribution was determined by computerized tomography scan in the PCOS adolescents. Main Outcome Measures: We measured the prevalence of MBS and its components in adolescent subjects and controls. Results: The PCOS group had larger ovarian volume and higher measures of total testosterone and free androgen index than controls, but there were no differences in waist circumference, fasting glucose, blood pressure, or lipids. PCOS adolescents demonstrated more glucose abnormalities and higher plasminogen activator inhibitor-1. By pediatric criteria, 53% of the PCOS and 55% of the control adolescents had MBS. By adult criteria, 26% of PCOS and 29% of controls met diagnostic criteria for MBS. Conclusions: Obese adolescent women have a high prevalence of MBS, and PCOS does not add additional risk for MBS. There appears to be an association between MBS and visceral adiposity. PCOS is associated with increased incidence of glucose intolerance and increased plasminogen activator inhibitor-1. Our results reinforce the importance of obesity counseling in adolescents to recognize the possible risk of future cardiovascular disease in these young women. Context: Adults with polycystic ovary syndrome (PCOS) may be at increased risk for metabolic syndrome (MBS) and related cardiovascular disease. It is not clear whether PCOS diagnosed in adolescence increases the risk of MBS in this age group. Objective: The aim was to compare the prevalence and related characteristics of MBS in obese adolescents with and without PCOS. Design: We conducted a cross-sectional study of overweight and obese PCOS adolescents and BMI matched controls. Patients and Participants: A total of 74 subjects, 43 with PCOS and 31 controls, participated in the study. Interventions: Each subject underwent a physical examination and laboratory evaluation for a diagnosis of MBS. Regional fat distribution was determined by computerized tomography scan in the PCOS adolescents. Main Outcome Measures: We measured the prevalence of MBS and its components in adolescent subjects and controls. Results: The PCOS group had larger ovarian volume and higher measures of total testosterone and free androgen index than controls, but there were no differences in waist circumference, fasting glucose, blood pressure, or lipids. PCOS adolescents demonstrated more glucose abnormalities and higher plasminogen activator inhibitor-1. By pediatric criteria, 53% of the PCOS and 55% of the control adolescents had MBS. By adult criteria, 26% of PCOS and 29% of controls met diagnostic criteria for MBS. Conclusions: Obese adolescent women have a high prevalence of MBS, and PCOS does not add additional risk for MBS. There appears to be an association between MBS and visceral adiposity. PCOS is associated with increased incidence of glucose intolerance and increased plasminogen activator inhibitor-1. Our results reinforce the importance of obesity counseling in adolescents to recognize the possible risk of future cardiovascular disease in these young women. Obese adolescent women have a high prevalence of metabolic syndrome irrespective of polycystic ovary syndrome status, which is associated with the amount of visceral adiposity. Adults with polycystic ovary syndrome (PCOS) may be at increased risk for metabolic syndrome (MBS) and related cardiovascular disease. It is not clear whether PCOS diagnosed in adolescence increases the risk of MBS in this age group.CONTEXTAdults with polycystic ovary syndrome (PCOS) may be at increased risk for metabolic syndrome (MBS) and related cardiovascular disease. It is not clear whether PCOS diagnosed in adolescence increases the risk of MBS in this age group.The aim was to compare the prevalence and related characteristics of MBS in obese adolescents with and without PCOS.OBJECTIVEThe aim was to compare the prevalence and related characteristics of MBS in obese adolescents with and without PCOS.We conducted a cross-sectional study of overweight and obese PCOS adolescents and BMI matched controls.DESIGNWe conducted a cross-sectional study of overweight and obese PCOS adolescents and BMI matched controls.A total of 74 subjects, 43 with PCOS and 31 controls, participated in the study.PATIENTS AND PARTICIPANTSA total of 74 subjects, 43 with PCOS and 31 controls, participated in the study.Each subject underwent a physical examination and laboratory evaluation for a diagnosis of MBS. Regional fat distribution was determined by computerized tomography scan in the PCOS adolescents.INTERVENTIONSEach subject underwent a physical examination and laboratory evaluation for a diagnosis of MBS. Regional fat distribution was determined by computerized tomography scan in the PCOS adolescents.We measured the prevalence of MBS and its components in adolescent subjects and controls.MAIN OUTCOME MEASURESWe measured the prevalence of MBS and its components in adolescent subjects and controls.The PCOS group had larger ovarian volume and higher measures of total testosterone and free androgen index than controls, but there were no differences in waist circumference, fasting glucose, blood pressure, or lipids. PCOS adolescents demonstrated more glucose abnormalities and higher plasminogen activator inhibitor-1. By pediatric criteria, 53% of the PCOS and 55% of the control adolescents had MBS. By adult criteria, 26% of PCOS and 29% of controls met diagnostic criteria for MBS.RESULTSThe PCOS group had larger ovarian volume and higher measures of total testosterone and free androgen index than controls, but there were no differences in waist circumference, fasting glucose, blood pressure, or lipids. PCOS adolescents demonstrated more glucose abnormalities and higher plasminogen activator inhibitor-1. By pediatric criteria, 53% of the PCOS and 55% of the control adolescents had MBS. By adult criteria, 26% of PCOS and 29% of controls met diagnostic criteria for MBS.Obese adolescent women have a high prevalence of MBS, and PCOS does not add additional risk for MBS. There appears to be an association between MBS and visceral adiposity. PCOS is associated with increased incidence of glucose intolerance and increased plasminogen activator inhibitor-1. Our results reinforce the importance of obesity counseling in adolescents to recognize the possible risk of future cardiovascular disease in these young women.CONCLUSIONSObese adolescent women have a high prevalence of MBS, and PCOS does not add additional risk for MBS. There appears to be an association between MBS and visceral adiposity. PCOS is associated with increased incidence of glucose intolerance and increased plasminogen activator inhibitor-1. Our results reinforce the importance of obesity counseling in adolescents to recognize the possible risk of future cardiovascular disease in these young women. Adults with polycystic ovary syndrome (PCOS) may be at increased risk for metabolic syndrome (MBS) and related cardiovascular disease. It is not clear whether PCOS diagnosed in adolescence increases the risk of MBS in this age group. The aim was to compare the prevalence and related characteristics of MBS in obese adolescents with and without PCOS. We conducted a cross-sectional study of overweight and obese PCOS adolescents and BMI matched controls. A total of 74 subjects, 43 with PCOS and 31 controls, participated in the study. Each subject underwent a physical examination and laboratory evaluation for a diagnosis of MBS. Regional fat distribution was determined by computerized tomography scan in the PCOS adolescents. We measured the prevalence of MBS and its components in adolescent subjects and controls. The PCOS group had larger ovarian volume and higher measures of total testosterone and free androgen index than controls, but there were no differences in waist circumference, fasting glucose, blood pressure, or lipids. PCOS adolescents demonstrated more glucose abnormalities and higher plasminogen activator inhibitor-1. By pediatric criteria, 53% of the PCOS and 55% of the control adolescents had MBS. By adult criteria, 26% of PCOS and 29% of controls met diagnostic criteria for MBS. Obese adolescent women have a high prevalence of MBS, and PCOS does not add additional risk for MBS. There appears to be an association between MBS and visceral adiposity. PCOS is associated with increased incidence of glucose intolerance and increased plasminogen activator inhibitor-1. Our results reinforce the importance of obesity counseling in adolescents to recognize the possible risk of future cardiovascular disease in these young women. |
Author | Sukalich, Sara Guzick, David S. Griffin, Adam Droz, Jennifer Blumkin, Aaron Hoeger, Kathleen M. Cook, Stephen Rossi, Brooke |
Author_xml | – sequence: 1 givenname: Brooke surname: Rossi fullname: Rossi, Brooke organization: 3Department of Obstetrics and Gynecology (B.R., A.G.), Brigham and Women’s Hospital, Boston, Massachusetts 02115 – sequence: 2 givenname: Sara surname: Sukalich fullname: Sukalich, Sara organization: 1Departments of Obstetrics and Gynecology (S.S., J.D., D.S.G., K.M.H.), University of Rochester Medical Center, Rochester, New York 14642 – sequence: 3 givenname: Jennifer surname: Droz fullname: Droz, Jennifer organization: 1Departments of Obstetrics and Gynecology (S.S., J.D., D.S.G., K.M.H.), University of Rochester Medical Center, Rochester, New York 14642 – sequence: 4 givenname: Adam surname: Griffin fullname: Griffin, Adam organization: 3Department of Obstetrics and Gynecology (B.R., A.G.), Brigham and Women’s Hospital, Boston, Massachusetts 02115 – sequence: 5 givenname: Stephen surname: Cook fullname: Cook, Stephen organization: 2Pediatrics (S.C., A.B.), University of Rochester Medical Center, Rochester, New York 14642 – sequence: 6 givenname: Aaron surname: Blumkin fullname: Blumkin, Aaron organization: 2Pediatrics (S.C., A.B.), University of Rochester Medical Center, Rochester, New York 14642 – sequence: 7 givenname: David S. surname: Guzick fullname: Guzick, David S. organization: 1Departments of Obstetrics and Gynecology (S.S., J.D., D.S.G., K.M.H.), University of Rochester Medical Center, Rochester, New York 14642 – sequence: 8 givenname: Kathleen M. surname: Hoeger fullname: Hoeger, Kathleen M. email: Kathy_hoeger@urmc.rochester.edu organization: 1Departments of Obstetrics and Gynecology (S.S., J.D., D.S.G., K.M.H.), University of Rochester Medical Center, Rochester, New York 14642 |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20971840$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/18812482$$D View this record in MEDLINE/PubMed |
BookMark | eNp1ktuLEzEYxYOsuN3VN58lIOqLsyaZzCUvwlK8wUoXL-BbyGS-sSlpUpNMpeAfb2Zbqy7sUwL5ncM55JyhE-cdIPSYkgvKKHm10heMkLagVLT30IwKXhUNFc0JmhHCaCEa9u0UncW4IoRyXpUP0CltW8p4y2bo13WArbLgNGA_4I-QVOet0fjzzvXBrwEr1-NPYFWCHs-XKiidIJiYjI7YOLzoIAK-7L2FqMGliH-atLxRTRc_Jnzt7U7vJgVebFXYHb0fovuDshEeHc5z9PXtmy_z98XV4t2H-eVVoXnJU8EHqJumJwKgIX1Fu0EIVRNeA2MdK3mpYVAl07TSFWu7roESBs0oVR2rWT-U5-j13nczdmvop5hBWbkJZp3jSK-M_P_FmaX87rcyy2vOWTZ4fjAI_scIMcm1yW2tVQ78GGUt2obyqs3g01vgyo_B5XKypNmKZFJk6sm_eY5B_nxLBp4dABW1skNQTpt45BgRDW05ydzLPaeDjzHA8NeKyGkdcqXltA45rSPj7BauTVLJ-Km1sXeJXuxFftzcZX8zvvI33RHLVw |
CODEN | JCEMAZ |
CitedBy_id | crossref_primary_10_1007_s11892_014_0564_3 crossref_primary_10_1016_j_jpag_2014_05_005 crossref_primary_10_1111_j_1365_2265_2009_03604_x crossref_primary_10_1155_2016_1473612 crossref_primary_10_1186_1472_6823_14_76 crossref_primary_10_1097_MED_0b013e32832afd4d crossref_primary_10_1016_j_jpag_2010_06_003 crossref_primary_10_1016_j_amepre_2024_10_009 crossref_primary_10_1080_01443615_2017_1318840 crossref_primary_10_3803_EnM_2018_33_4_447 crossref_primary_10_1016_j_dsx_2019_01_002 crossref_primary_10_1016_j_jpag_2018_03_001 crossref_primary_10_1016_j_fertnstert_2014_05_032 crossref_primary_10_1159_000471804 crossref_primary_10_1016_j_jpag_2012_07_006 crossref_primary_10_3109_09513590_2011_613968 crossref_primary_10_1186_1477_7827_8_142 crossref_primary_10_1111_j_1471_0528_2009_02386_x crossref_primary_10_1016_j_dsx_2018_03_014 crossref_primary_10_1111_j_1399_5448_2009_00559_x crossref_primary_10_20945_2359_3997000000497 crossref_primary_10_1016_j_ejogrb_2020_04_024 crossref_primary_10_1016_j_fertnstert_2013_04_001 crossref_primary_10_1542_peds_2015_1430 crossref_primary_10_4103_jnsm_jnsm_140_20 crossref_primary_10_1007_s11154_009_9115_7 crossref_primary_10_3109_09513590903015528 crossref_primary_10_1556_OH_2013_29669 crossref_primary_10_1016_j_jpag_2014_08_011 crossref_primary_10_1590_S0004_27302009000200014 crossref_primary_10_1016_j_jadohealth_2017_09_005 crossref_primary_10_1097_GCO_0b013e32832e07d5 crossref_primary_10_1177_1358863X16682107 crossref_primary_10_1016_j_bpobgyn_2009_09_005 crossref_primary_10_1016_j_jpeds_2012_11_019 crossref_primary_10_1111_j_1447_0756_2010_01516_x crossref_primary_10_1210_jendso_bvab060 crossref_primary_10_1177_0897190010384632 crossref_primary_10_1097_MED_0b013e32835a1a03 crossref_primary_10_1530_EJE_09_1102 crossref_primary_10_15406_emij_2018_06_00158 crossref_primary_10_1097_MED_0b013e32832c937e crossref_primary_10_1111_cob_12123 crossref_primary_10_1155_2012_434830 crossref_primary_10_36106_ijsr_1814624 crossref_primary_10_1159_000375530 crossref_primary_10_1016_j_ogc_2008_12_004 crossref_primary_10_1210_er_2015_1104 crossref_primary_10_1016_j_fertnstert_2013_12_046 crossref_primary_10_1111_cen_13477 crossref_primary_10_1016_j_fertnstert_2010_03_048 crossref_primary_10_1016_j_fertnstert_2011_03_001 crossref_primary_10_1016_j_jpag_2014_10_010 crossref_primary_10_1016_j_jadohealth_2020_07_008 crossref_primary_10_1016_j_rbmo_2019_06_014 crossref_primary_10_1159_000435883 crossref_primary_10_1016_j_fertnstert_2015_09_005 crossref_primary_10_2217_phe_09_69 crossref_primary_10_1016_j_fertnstert_2011_09_043 crossref_primary_10_1530_EJE_16_0374 crossref_primary_10_1016_j_fertnstert_2015_08_002 crossref_primary_10_1111_j_1464_5491_2010_02994_x crossref_primary_10_1007_s13679_020_00388_9 crossref_primary_10_1016_j_jpeds_2015_09_082 crossref_primary_10_1080_01443615_2017_1345875 crossref_primary_10_1556_OH_2013_29527 crossref_primary_10_53394_akd_1037762 crossref_primary_10_3109_09513590_2012_708802 crossref_primary_10_1007_s13679_012_0030_y crossref_primary_10_3892_etm_2017_4642 crossref_primary_10_1177_20420188211066699 crossref_primary_10_1111_j_1600_0412_2012_01417_x crossref_primary_10_1016_j_jpag_2019_01_006 crossref_primary_10_3109_09513590_2010_508851 crossref_primary_10_1155_2013_972034 crossref_primary_10_1016_j_steroids_2013_04_011 crossref_primary_10_1530_EJE_10_0205 |
Cites_doi | 10.1097/GRF.0b013e31802f3547 10.1016/S0021-9150(02)00236-8 10.1016/S0140-6736(07)60958-1 10.1016/j.jpeds.2007.09.010 10.1111/j.1399-5448.2007.00271.x 10.1210/jc.2005-1002 10.1210/jc.2003-032049 10.1093/humrep/15.4.785 10.1093/humrep/deg190 10.1016/S0015-0282(03)00265-6 10.1210/jc.2005-1666 10.1001/archpedi.157.8.821 10.1001/jama.295.13.1549 10.1016/S0015-0282(97)00486-X 10.1093/humrep/dei258 10.1016/j.atherosclerosis.2005.10.007 10.1016/j.fertnstert.2003.10.004 10.1210/jc.2005-1707 10.1210/jc.2007-2117 10.1542/peds.2006-1062 10.1177/009127002762491271 10.1016/S0895-4356(98)00010-9 10.1542/peds.2006-1699 10.1016/j.jpeds.2007.06.004 10.1210/jc.2007-1343 10.1016/S0140-6736(05)67402-8 10.1161/CIRCULATIONAHA.105.169404 10.1161/01.ATV.15.7.821 10.1016/j.atherosclerosis.2003.12.022 10.1097/GRF.0b013e31802f50fc 10.1210/jc.2005-1329 10.1161/HYPERTENSIONAHA.106.083972 10.1210/jc.2003-032046 10.1093/humrep/16.6.1255 10.1210/jc.2006-2725 10.1210/jc.2007-1834 10.1507/endocrj.51.467 |
ContentType | Journal Article |
Copyright | Copyright © 2008 by The Endocrine Society 2008 2009 INIST-CNRS Copyright © 2008 by The Endocrine Society Copyright © 2008 by The Endocrine Society 2008 |
Copyright_xml | – notice: Copyright © 2008 by The Endocrine Society 2008 – notice: 2009 INIST-CNRS – notice: Copyright © 2008 by The Endocrine Society – notice: Copyright © 2008 by The Endocrine Society 2008 |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7QP 7T5 7TM H94 K9. 7X8 5PM |
DOI | 10.1210/jc.2008-1198 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts Immunology Abstracts Nucleic Acids Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Calcium & Calcified Tissue Abstracts Nucleic Acids Abstracts MEDLINE - Academic |
DatabaseTitleList | CrossRef AIDS and Cancer Research Abstracts MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1945-7197 |
EndPage | 4786 |
ExternalDocumentID | PMC2626442 18812482 20971840 10_1210_jc_2008_1198 10.1210/jc.2008-1198 |
Genre | Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NHLBI NIH HHS grantid: K23 HL086946 – fundername: NICHD NIH HHS grantid: K23 HD043881 – fundername: NCRR NIH HHS grantid: UL1 RR024160 – fundername: NHLBI NIH HHS grantid: K23 HL086946-01A1 – fundername: NICHD NIH HHS grantid: K23 HD043881-01A1 – fundername: NICHD NIH HHS grantid: R03 HD041989 – fundername: NCRR NIH HHS grantid: UL1 RR 024160 – fundername: NICHD NIH HHS grantid: 5 R03 HD41989-02 |
GroupedDBID | --- -~X .55 .XZ 08P 0R~ 18M 1TH 29K 2WC 34G 354 39C 4.4 48X 53G 5GY 5RS 5YH 8F7 AABZA AACZT AAIMJ AAPQZ AAPXW AARHZ AAUAY AAVAP AAWTL ABBLC ABDFA ABEJV ABGNP ABJNI ABLJU ABMNT ABNHQ ABOCM ABPMR ABPPZ ABPQP ABPTD ABQNK ABVGC ABWST ABXVV ACGFO ACGFS ACPRK ACUTJ ACYHN ADBBV ADGKP ADGZP ADHKW ADQBN ADRTK ADVEK AELWJ AEMDU AENEX AENZO AERZD AETBJ AEWNT AFCHL AFFNX AFFZL AFGWE AFOFC AFRAH AFXAL AGINJ AGKRT AGQXC AGUTN AHMBA AHMMS AJEEA ALMA_UNASSIGNED_HOLDINGS APIBT ARIXL ASPBG ATGXG AVWKF AZFZN BAWUL BAYMD BCRHZ BEYMZ BSWAC BTRTY C45 CDBKE CS3 D-I DAKXR DIK E3Z EBS EJD EMOBN ENERS F5P FECEO FHSFR FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H13 HZ~ H~9 KBUDW KOP KQ8 KSI KSN L7B M5~ MHKGH MJL N4W N9A NLBLG NOMLY NOYVH NVLIB O9- OAUYM OBH OCB ODMLO OFXIZ OGEVE OHH OJZSN OK1 OPAEJ OVD OVIDX P2P P6G REU ROX ROZ TEORI TJX TLC TR2 TWZ VVN W8F WOQ X7M YBU YFH YHG YOC YSK ZY1 ~02 ~H1 AAYXX ABXZS ADNBA AEMQT AEOTA AFYAG AGORE ALXQX CITATION NU- .GJ 3O- 7X7 88E 8FI 8FJ AAJQQ AAKAS AAPGJ AAQQT AAUQX AAWDT AAYJJ ABDPE ABUWG ACFRR ACVCV ACZBC ADMTO ADZCM AFFQV AFKRA AGMDO AHGBF AI. AJBYB AJDVS APJGH AQDSO AQKUS AVNTJ BENPR BPHCQ BVXVI CCPQU EIHJH FEDTE FYUFA HMCUK HVGLF IAO IHR INH IQODW ITC J5H M1P MBLQV OBFPC PHGZM PHGZT PJZUB PPXIY PQQKQ PROAC PSQYO TMA UKHRP VH1 WHG X52 ZGI ZXP CGR CUY CVF ECM EIF NPM 7QP 7T5 7TM AEHZK H94 K9. 7X8 5PM |
ID | FETCH-LOGICAL-c434t-4fe677d09ee70d51bf99a6046e22b2343cefa32c15c528bb7e3efc211ab262df3 |
ISSN | 0021-972X |
IngestDate | Thu Aug 21 18:09:12 EDT 2025 Mon Sep 08 12:45:53 EDT 2025 Fri Sep 19 20:58:35 EDT 2025 Mon Jul 21 05:22:24 EDT 2025 Mon Jul 21 09:17:05 EDT 2025 Tue Jul 01 04:01:29 EDT 2025 Thu Apr 24 22:50:31 EDT 2025 Fri Feb 07 10:35:41 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Keywords | Endocrinopathy Human Obesity Prevalence Nutrition Nutrition disorder Cardiovascular disease Female sterility Metabolic diseases Polycystic ovary Metabolic syndrome Epidemiology Female genital diseases Ovarian diseases Cyst Adolescent Benign neoplasm Endocrinology Nutritional status |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c434t-4fe677d09ee70d51bf99a6046e22b2343cefa32c15c528bb7e3efc211ab262df3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Address all correspondence and requests for reprints to: Kathleen Hoeger, M.D., Associate Professor of Obstetrics and Gynecology, University of Rochester Medical Center, 601 Elmwood Avenue, Box 668, Rochester, New York 14642. E-mail: Kathy_hoeger@urmc.rochester.edu. |
PMID | 18812482 |
PQID | 3164406989 |
PQPubID | 2046206 |
PageCount | 7 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_2626442 proquest_miscellaneous_69871458 proquest_journals_3164406989 pubmed_primary_18812482 pascalfrancis_primary_20971840 crossref_primary_10_1210_jc_2008_1198 crossref_citationtrail_10_1210_jc_2008_1198 oup_primary_10_1210_jc_2008-1198 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2008-12-01 |
PublicationDateYYYYMMDD | 2008-12-01 |
PublicationDate_xml | – month: 12 year: 2008 text: 2008-12-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Bethesda, MD |
PublicationPlace_xml | – name: Bethesda, MD – name: United States – name: Washington |
PublicationTitle | The journal of clinical endocrinology and metabolism |
PublicationTitleAlternate | J Clin Endocrinol Metab |
PublicationYear | 2008 |
Publisher | Oxford University Press Endocrine Society The Endocrine Society |
Publisher_xml | – name: Oxford University Press – name: Endocrine Society – name: The Endocrine Society |
References | Ogden (2020071613345343400_R16) 2006; 295 Chen (2020071613345343400_R32) 2007; 49 Shroff (2020071613345343400_R29) 2007; 92 Talbott (2020071613345343400_R9) 1995; 15 Chang (2020071613345343400_R19) 2007; 50 Alberti (2020071613345343400_R14) 2005; 366 Zimmet (2020071613345343400_R13) 2007; 369 Azziz (2020071613345343400_R15) 2004; 89 Grundy (2020071613345343400_R11) 2005; 112 Ehrmann (2020071613345343400_R33) 2006; 91 Arslanian (2020071613345343400_R34) 2001; 86 Kirchengast (2020071613345343400_R22) 2001; 16 Yilmaz (2020071613345343400_R28) 2005; 20 Morrison (2020071613345343400_R39) 2008; 152 Coviello (2020071613345343400_R4) 2006; 91 Essah (2020071613345343400_R2) 2007; 50 Li (2020071613345343400_R18) 2006; 118 Cibula (2020071613345343400_R31) 2000; 15 Dunaif (2020071613345343400_R30) 1997; 18 Zimmet (2020071613345343400_R12) 2007; 8 Schachter (2020071613345343400_R27) 2003; 18 Tsikouris (2020071613345343400_R37) 2002; 42 Morrison (2020071613345343400_R38) 2007; 120 Ford (2020071613345343400_R6) 2004; 173 Onat (2020071613345343400_R7) 2002; 165 Cussons (2020071613345343400_R25) 2006; 185 Yildirim (2020071613345343400_R23) 2003; 79 Tarkun (2020071613345343400_R36) 2004; 51 Talbott (2020071613345343400_R8) 1998; 51 Cook (2020071613345343400_R10) 2003; 157 Leibel (2020071613345343400_R5) 2006; 91 Barber (2020071613345343400_R24) 2008; 93 Puder (2020071613345343400_R21) 2005; 90 Atiomo (2020071613345343400_R35) 1998; 69 Cook (2020071613345343400_R3) 2008; 152 Yildiz (2020071613345343400_R17) 2008; 93 Orio Jr (2020071613345343400_R26) 2004; 89 Carmina (2020071613345343400_R20) 2007; 92 Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2020071613345343400_R1) 2004; 81 16182882 - Lancet. 2005 Sep 24-30;366(9491):1059-62 11387301 - Hum Reprod. 2001 Jun;16(6):1255-60 9619969 - J Clin Epidemiol. 1998 May;51(5):415-22 17304037 - Clin Obstet Gynecol. 2007 Mar;50(1):205-25 16249284 - J Clin Endocrinol Metab. 2006 Jan;91(1):48-53 17304035 - Clin Obstet Gynecol. 2007 Mar;50(1):178-87 15064107 - Atherosclerosis. 2004 Apr;173(2):309-14 17925334 - J Clin Endocrinol Metab. 2008 Jan;93(1):162-8 17405838 - J Clin Endocrinol Metab. 2007 Jul;92(7):2500-5 12912790 - Arch Pediatr Adolesc Med. 2003 Aug;157(8):821-7 17671060 - Pediatrics. 2007 Aug;120(2):340-5 18206689 - J Pediatr. 2008 Feb;152(2):201-6 10739820 - Hum Reprod. 2000 Apr;15(4):785-9 17848406 - J Clin Endocrinol Metab. 2007 Dec;92(12):4609-14 7600112 - Arterioscler Thromb Vasc Biol. 1995 Jul;15(7):821-6 12660262 - Hum Reprod. 2003 Apr;18(4):721-7 16105965 - J Clin Endocrinol Metab. 2005 Nov;90(11):6014-21 17079540 - Pediatrics. 2006 Nov;118(5):e1390-8 17389259 - Hypertension. 2007 Jun;49(6):1442-7 16449341 - J Clin Endocrinol Metab. 2006 Apr;91(4):1275-83 16249280 - J Clin Endocrinol Metab. 2006 Feb;91(2):492-7 9496335 - Fertil Steril. 1998 Feb;69(2):236-41 12798883 - Fertil Steril. 2003 Jun;79(6):1358-64 14711538 - Fertil Steril. 2004 Jan;81(1):19-25 15181052 - J Clin Endocrinol Metab. 2004 Jun;89(6):2745-9 16595758 - JAMA. 2006 Apr 5;295(13):1549-55 15516780 - Endocr J. 2004 Oct;51(5):467-72 16123091 - Hum Reprod. 2005 Dec;20(12):3333-40 18089693 - J Clin Endocrinol Metab. 2008 Mar;93(3):999-1004 12412817 - J Clin Pharmacol. 2002 Nov;42(11):1187-99 17850473 - Pediatr Diabetes. 2007 Oct;8(5):299-306 17586288 - Lancet. 2007 Jun 23;369(9579):2059-61 16313910 - Atherosclerosis. 2006 Apr;185(2):227-39 16157765 - Circulation. 2005 Oct 25;112(17):2735-52 18206683 - J Pediatr. 2008 Feb;152(2):165-70 12417279 - Atherosclerosis. 2002 Dec;165(2):285-92 11231980 - J Clin Endocrinol Metab. 2001 Jan;86(1):66-71 15292291 - J Clin Endocrinol Metab. 2004 Aug;89(8):3696-701 9408743 - Endocr Rev. 1997 Dec;18(6):774-800 |
References_xml | – volume: 50 start-page: 205 year: 2007 ident: 2020071613345343400_R2 article-title: The metabolic syndrome in polycystic ovary syndrome. publication-title: Clin Obstet Gynecol doi: 10.1097/GRF.0b013e31802f3547 – volume: 165 start-page: 285 year: 2002 ident: 2020071613345343400_R7 article-title: Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels—a prospective and cross-sectional evaluation. publication-title: Atherosclerosis doi: 10.1016/S0021-9150(02)00236-8 – volume: 369 start-page: 2059 year: 2007 ident: 2020071613345343400_R13 article-title: The metabolic syndrome in children and adolescents. publication-title: Lancet doi: 10.1016/S0140-6736(07)60958-1 – volume: 152 start-page: 201 year: 2008 ident: 2020071613345343400_R39 article-title: Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabetes mellitus 25 to 30 years later. publication-title: J Pediatr doi: 10.1016/j.jpeds.2007.09.010 – volume: 8 start-page: 299 year: 2007 ident: 2020071613345343400_R12 article-title: The metabolic syndrome in children and adolescents - an IDF consensus report. publication-title: Pediatr Diabetes doi: 10.1111/j.1399-5448.2007.00271.x – volume: 90 start-page: 6014 year: 2005 ident: 2020071613345343400_R21 article-title: Central fat excess in polycystic ovary syndrome: relation to low-grade inflammation and insulin resistance. publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2005-1002 – volume: 89 start-page: 3696 year: 2004 ident: 2020071613345343400_R26 article-title: The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study. publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2003-032049 – volume: 15 start-page: 785 year: 2000 ident: 2020071613345343400_R31 article-title: Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome. publication-title: Hum Reprod doi: 10.1093/humrep/15.4.785 – volume: 18 start-page: 721 year: 2003 ident: 2020071613345343400_R27 article-title: Insulin resistance in patients with polycystic ovary syndrome is associated with elevated plasma homocysteine. publication-title: Hum Reprod doi: 10.1093/humrep/deg190 – volume: 79 start-page: 1358 year: 2003 ident: 2020071613345343400_R23 article-title: Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome. publication-title: Fertil Steril doi: 10.1016/S0015-0282(03)00265-6 – volume: 91 start-page: 492 year: 2006 ident: 2020071613345343400_R4 article-title: Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2005-1666 – volume: 157 start-page: 821 year: 2003 ident: 2020071613345343400_R10 article-title: Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988–1994. publication-title: Arch Pediatr Adolesc Med doi: 10.1001/archpedi.157.8.821 – volume: 295 start-page: 1549 year: 2006 ident: 2020071613345343400_R16 article-title: Prevalence of overweight and obesity in the united states, 1999–2004. publication-title: JAMA doi: 10.1001/jama.295.13.1549 – volume: 69 start-page: 236 year: 1998 ident: 2020071613345343400_R35 article-title: The plasminogen activator system in women with polycystic ovary syndrome. publication-title: Fertil Steril doi: 10.1016/S0015-0282(97)00486-X – volume: 20 start-page: 3333 year: 2005 ident: 2020071613345343400_R28 article-title: The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome. publication-title: Hum Reprod doi: 10.1093/humrep/dei258 – volume: 185 start-page: 227 year: 2006 ident: 2020071613345343400_R25 article-title: Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives. publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2005.10.007 – volume: 81 start-page: 19 year: 2004 ident: 2020071613345343400_R1 article-title: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. publication-title: Fertil Steril doi: 10.1016/j.fertnstert.2003.10.004 – volume: 91 start-page: 1275 year: 2006 ident: 2020071613345343400_R5 article-title: Relationship of adolescent polycystic ovary syndrome to parental metabolic syndrome. publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2005-1707 – volume: 18 start-page: 774 year: 1997 ident: 2020071613345343400_R30 article-title: Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. publication-title: Endocr Rev – volume: 93 start-page: 999 year: 2008 ident: 2020071613345343400_R24 article-title: Global adiposity rather than abnormal regional fat distribution characterizes women with polycystic ovary syndrome. publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2007-2117 – volume: 118 start-page: e1390 year: 2006 ident: 2020071613345343400_R18 article-title: Recent trends in waist circumference and waist-height ratio among US children and adolescents publication-title: Pediatrics doi: 10.1542/peds.2006-1062 – volume: 42 start-page: 1187 year: 2002 ident: 2020071613345343400_R37 article-title: Plasminogen activator inhibitor-1: physiologic role, regulation, and the influence of common pharmacologic agents. publication-title: J Clin Pharmacol doi: 10.1177/009127002762491271 – volume: 51 start-page: 415 year: 1998 ident: 2020071613345343400_R8 article-title: Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study. publication-title: J Clin Epidemiol doi: 10.1016/S0895-4356(98)00010-9 – volume: 120 start-page: 340 year: 2007 ident: 2020071613345343400_R38 article-title: Metabolic syndrome in childhood predicts adult cardiovascular disease 25 years later: the Princeton Lipid Research Clinic Follow-up Study. publication-title: Pediatrics doi: 10.1542/peds.2006-1699 – volume: 152 start-page: 165 year: 2008 ident: 2020071613345343400_R3 article-title: Metabolic syndrome rates in United States adolescents, from the National Health and Nutrition Examination Survey, 1999–2002. publication-title: J Pediatr doi: 10.1016/j.jpeds.2007.06.004 – volume: 92 start-page: 4609 year: 2007 ident: 2020071613345343400_R29 article-title: Young obese women with polycystic ovary syndrome have evidence of early coronary atherosclerosis. publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2007-1343 – volume: 366 start-page: 1059 year: 2005 ident: 2020071613345343400_R14 article-title: The metabolic syndrome—a new worldwide definition. publication-title: Lancet doi: 10.1016/S0140-6736(05)67402-8 – volume: 112 start-page: 2735 year: 2005 ident: 2020071613345343400_R11 article-title: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.105.169404 – volume: 15 start-page: 821 year: 1995 ident: 2020071613345343400_R9 article-title: Coronary heart disease risk factors in women with polycystic ovary syndrome. publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/01.ATV.15.7.821 – volume: 173 start-page: 309 year: 2004 ident: 2020071613345343400_R6 article-title: The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II mortality study. publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2003.12.022 – volume: 50 start-page: 178 year: 2007 ident: 2020071613345343400_R19 article-title: Polycystic ovary syndrome: early detection in the adolescent. publication-title: Clin Obstet Gynecol doi: 10.1097/GRF.0b013e31802f50fc – volume: 91 start-page: 48 year: 2006 ident: 2020071613345343400_R33 article-title: Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2005-1329 – volume: 86 start-page: 66 year: 2001 ident: 2020071613345343400_R34 article-title: Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and β-cell dysfunction and risk of cardiovascular disease. publication-title: J Clin Endocrinol Metab – volume: 49 start-page: 1442 year: 2007 ident: 2020071613345343400_R32 article-title: Relationship between androgen levels and blood pressure in young women with polycystic ovary syndrome. publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.106.083972 – volume: 89 start-page: 2745 year: 2004 ident: 2020071613345343400_R15 article-title: The prevalence and features of the polycystic ovary syndrome in an unselected population. publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2003-032046 – volume: 16 start-page: 1255 year: 2001 ident: 2020071613345343400_R22 article-title: Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome. publication-title: Hum Reprod doi: 10.1093/humrep/16.6.1255 – volume: 92 start-page: 2500 year: 2007 ident: 2020071613345343400_R20 article-title: Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance. publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2006-2725 – volume: 93 start-page: 162 year: 2008 ident: 2020071613345343400_R17 article-title: Impact of obesity on the risk for polycystic ovary syndrome. publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2007-1834 – volume: 51 start-page: 467 year: 2004 ident: 2020071613345343400_R36 article-title: The plasminogen activator system in young and lean women with polycystic ovary syndrome. publication-title: Endocr J doi: 10.1507/endocrj.51.467 – reference: 16249280 - J Clin Endocrinol Metab. 2006 Feb;91(2):492-7 – reference: 17304035 - Clin Obstet Gynecol. 2007 Mar;50(1):178-87 – reference: 14711538 - Fertil Steril. 2004 Jan;81(1):19-25 – reference: 17586288 - Lancet. 2007 Jun 23;369(9579):2059-61 – reference: 12798883 - Fertil Steril. 2003 Jun;79(6):1358-64 – reference: 15292291 - J Clin Endocrinol Metab. 2004 Aug;89(8):3696-701 – reference: 16249284 - J Clin Endocrinol Metab. 2006 Jan;91(1):48-53 – reference: 12417279 - Atherosclerosis. 2002 Dec;165(2):285-92 – reference: 16105965 - J Clin Endocrinol Metab. 2005 Nov;90(11):6014-21 – reference: 17079540 - Pediatrics. 2006 Nov;118(5):e1390-8 – reference: 17405838 - J Clin Endocrinol Metab. 2007 Jul;92(7):2500-5 – reference: 17389259 - Hypertension. 2007 Jun;49(6):1442-7 – reference: 18206683 - J Pediatr. 2008 Feb;152(2):165-70 – reference: 15516780 - Endocr J. 2004 Oct;51(5):467-72 – reference: 16313910 - Atherosclerosis. 2006 Apr;185(2):227-39 – reference: 18206689 - J Pediatr. 2008 Feb;152(2):201-6 – reference: 11231980 - J Clin Endocrinol Metab. 2001 Jan;86(1):66-71 – reference: 12660262 - Hum Reprod. 2003 Apr;18(4):721-7 – reference: 16595758 - JAMA. 2006 Apr 5;295(13):1549-55 – reference: 15181052 - J Clin Endocrinol Metab. 2004 Jun;89(6):2745-9 – reference: 16449341 - J Clin Endocrinol Metab. 2006 Apr;91(4):1275-83 – reference: 9408743 - Endocr Rev. 1997 Dec;18(6):774-800 – reference: 17304037 - Clin Obstet Gynecol. 2007 Mar;50(1):205-25 – reference: 16123091 - Hum Reprod. 2005 Dec;20(12):3333-40 – reference: 17925334 - J Clin Endocrinol Metab. 2008 Jan;93(1):162-8 – reference: 17850473 - Pediatr Diabetes. 2007 Oct;8(5):299-306 – reference: 16157765 - Circulation. 2005 Oct 25;112(17):2735-52 – reference: 9619969 - J Clin Epidemiol. 1998 May;51(5):415-22 – reference: 17848406 - J Clin Endocrinol Metab. 2007 Dec;92(12):4609-14 – reference: 9496335 - Fertil Steril. 1998 Feb;69(2):236-41 – reference: 18089693 - J Clin Endocrinol Metab. 2008 Mar;93(3):999-1004 – reference: 7600112 - Arterioscler Thromb Vasc Biol. 1995 Jul;15(7):821-6 – reference: 12412817 - J Clin Pharmacol. 2002 Nov;42(11):1187-99 – reference: 17671060 - Pediatrics. 2007 Aug;120(2):340-5 – reference: 11387301 - Hum Reprod. 2001 Jun;16(6):1255-60 – reference: 10739820 - Hum Reprod. 2000 Apr;15(4):785-9 – reference: 12912790 - Arch Pediatr Adolesc Med. 2003 Aug;157(8):821-7 – reference: 15064107 - Atherosclerosis. 2004 Apr;173(2):309-14 – reference: 16182882 - Lancet. 2005 Sep 24-30;366(9491):1059-62 |
SSID | ssj0014453 |
Score | 2.2943532 |
Snippet | Context: Adults with polycystic ovary syndrome (PCOS) may be at increased risk for metabolic syndrome (MBS) and related cardiovascular disease. It is not clear... Adults with polycystic ovary syndrome (PCOS) may be at increased risk for metabolic syndrome (MBS) and related cardiovascular disease. It is not clear whether... Context: Adults with polycystic ovary syndrome (PCOS) may be at increased risk for metabolic syndrome (MBS) and related cardiovascular disease. It is not clear... |
SourceID | pubmedcentral proquest pubmed pascalfrancis crossref oup |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 4780 |
SubjectTerms | Adipose tissue Adipose Tissue - pathology Adiposity - physiology Adolescent Adolescents Anthropometry Biological and medical sciences Biomarkers Blood Glucose - metabolism Blood pressure Blood Pressure - physiology Body Mass Index Cardiovascular disease Cardiovascular diseases Cardiovascular Diseases - complications Cardiovascular Diseases - epidemiology Child Cholesterol, HDL - blood Computed tomography Cross-Sectional Studies Endocrinopathies Feeding. Feeding behavior Female Fundamental and applied biological sciences. Psychology Glucose Glucose tolerance Humans Lipids Medical sciences Metabolic syndrome Metabolic Syndrome - complications Metabolic Syndrome - epidemiology Obesity Obesity - complications Obesity - epidemiology Original Ovaries Pediatrics Plasminogen Activator Inhibitor 1 - blood Plasminogen activator inhibitors Polycystic ovary syndrome Polycystic Ovary Syndrome - complications Polycystic Ovary Syndrome - epidemiology Risk Factors Teenagers Testosterone Tomography, X-Ray Computed Triglycerides - blood Vertebrates: anatomy and physiology, studies on body, several organs or systems Vertebrates: endocrinology Waist Circumference |
Title | Prevalence of Metabolic Syndrome and Related Characteristics in Obese Adolescents with and without Polycystic Ovary Syndrome |
URI | https://www.ncbi.nlm.nih.gov/pubmed/18812482 https://www.proquest.com/docview/3164406989 https://www.proquest.com/docview/69871458 https://pubmed.ncbi.nlm.nih.gov/PMC2626442 |
Volume | 93 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb9QwELaWIiEkhLhJKcUP8LQK2jhOnH1EFaiAOKS2Ut8i27HFwjapuruVWvEX-U_MxM612hXHS5Rj4hzzxZ5xZr4h5GVkoMtjKg2NkeCgaGZDBYZ9mCk2tdyAxaHrKN_P6eEJ_3CanI5Gv3pRS6uleq2vN-aV_I9WYR_oFbNk_0GzbaOwA9ZBv7AEDcPyr3SM_EuyzhqqI1nMEjSKpNVHnobAZx_OJZqVB2vUzLNyjFUBjK-ypIepbriCIctfq_mVvsIzxl8uMcLuaAPFAWKtR0HRZluasqigVyo7nqczf4-et9CVdlzMHMqQ_bP7SfUDPARXpwpnrVuD-6K67kfldPFDOPnk-BAKeTaYzMjWAkO2JEn2O3CMKBF1BXYYvlyfPeVJKCIX5tt06q7sYgNe1uuiuXClo_xwD5vpxqEEfGEcSmqaS7jPyBXLXiPn3ix4g9xkAkw5tNHff2x_anHuSVH9M_g8DEyi6p89sJBc1uWdc7kAtVlXa2WTM7Qe09szko7vkbveu6FvHFTvk5EpH5Bbn3z8xkPys0MsrSxtEUsbVFEACfWIpWuIpbOS1oilPcRSBGp9lkcs7RBLa8S2bT8iJ-_eHh8chr7-R6h5zJchtyYVophMjRGTIomUnU5lOuGpYUyxmMfaWBkzHSU6YZlSwsTGahZFUrGUFTZ-THbKqjRPCRUiNYWKMystToCkisdKFLwAC1FAuzIg4-ad59qT42ONlnmOTjJoKP-uXcVW1FBAXrXS544UZoscBfVtEwmdyP5At60wQ3K3jE8CstcoO_df8iKPI3BjJlj7NSAv2sMwMODfPlmaarXI4aiIeAJXeOKQ0d1HhlZ9xgIiBphpBZByfniknH2rqefhvcKV2e6fH-wZud194HtkZ3mxMs_Bfl-q_fqr-A3jzPZf |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prevalence+of+Metabolic+Syndrome+and+Related+Characteristics+in+Obese+Adolescents+with+and+without+Polycystic+Ovary+Syndrome&rft.jtitle=The+journal+of+clinical+endocrinology+and+metabolism&rft.au=Rossi%2C+Brooke&rft.au=Sukalich%2C+Sara&rft.au=Droz%2C+Jennifer&rft.au=Griffin%2C+Adam&rft.date=2008-12-01&rft.pub=Oxford+University+Press&rft.issn=0021-972X&rft.eissn=1945-7197&rft.volume=93&rft.issue=12&rft.spage=4780&rft.epage=4786&rft_id=info:doi/10.1210%2Fjc.2008-1198&rft.externalDocID=10.1210%2Fjc.2008-1198 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-972X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-972X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-972X&client=summon |